| NOVO-NORDISK B ADR/1DK 10 |
| USA |
| Gesundheit |
| US6701002056 / 866931 |
| NOVA (Frankfurt) / NVO (NYSE) |
| FRA:NOVA, ETR:NOVA, NOVA:GR, NYSE:NVO |
| - |
| https://www.novonordisk.c.. |
|
Novo Nordisk is a leading global pharmaceutical company headquartered in Denmark that specializes in developing and manufacturing medicines to treat serious chronic diseases. The company focuses on four primary therapeutic areas: diabetes, obesity, c..
>Volltext.. |
| 178191.81 Mio. EUR |
| 194738.43 Mio. EUR |
| 43792.63 Mio. EUR |
| 22799.85 Mio. EUR |
| 16303.16 Mio. EUR |
| 3.67 EUR |
| 19414.92 Mio. EUR |
| 2802.11 Mio. EUR |
| - |
| 0.1 |
| 16.79% |
| 25.96% |
| 1.61 EUR |
| 2.75% |
| 2.76% |
| 30.03.26 - 1.1122706€ 18.08.25 - 0.5013465€ >weitere anzeigen... |
| - |
| NOVO NORDISK ADR, NOVO NORDISK, NOVONORDISK |
| 19.05.26 |
|